• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Toxicology case studies: medications affecting the nervous system (Proceedings)

May 1, 2011
Camille DeClementi, VMD, DABT, DABVT

Citalopram is a Selective Serotonin Reuptake Inhibitor (SSRI). The therapeutic dose in dogs is 1 mg/kg PO q 24 h. Per APCC Database: 1 mg/kg depression and 29 mg/kg tremors, seizures. Citalopram overdose results in serotonin syndrome. Serotonin syndrome is a complex group of clinical signs resulting from the over stimulation of serotonin receptors and can include the following:

Citalopram

Citalopram is a Selective Serotonin Reuptake Inhibitor (SSRI). The therapeutic dose in dogs is 1 mg/kg PO q 24 h. Per APCC Database: 1 mg/kg depression and 29 mg/kg tremors, seizures. Citalopram overdose results in serotonin syndrome. Serotonin syndrome is a complex group of clinical signs resulting from the over stimulation of serotonin receptors and can include the following: 1. CNS effects: dementia, disorientation, agitation and seizures, 2. Autonomic effects: salivation, vomiting, diarrhea, hyperthermia, hyper/hypotension, mydriasis and 3. Neuromuscular effects: rigidity, hyperreflexia, ataxia and tremors. In humans, it is most commonly associated with concurrent or consecutive use of two serotonergic drugs. Serotonin syndrome is a severe, often life-threatening condition which requires immediate and aggressive treatment with close monitoring.

Advertisement

In veterinary medicine serotonin syndrome has been reported with overdoses of serotonergic agents. The signs of serotonin syndrome in dogs include hyperthermia, diarrhea, depression or agitation, disorientation, vocalization, tremors, seizures, vomiting, ataxia and clinical blindness.

Treatment includes stabilizing the patient then deciding on decontamination. Emesis is indicated if the patient is asymptomatic and no other contraindications. Activated charcoal may also be used. Supportive care will include managing seizures, tremors or rigidity, hyperthermia and GI signs, providing CV support, monitoring acid/base, electrolytes, EKG and blood pressure. There is a significant risk for DIC, rhabdomyolysis, or multi-organ failure if prolonged seizures or hyperthermia. Cyproheptadine is a non-selective serotonin antagonist that aids with hyperthermia, vocalization and disorientation. The dose is 1.1 mg/kg PO or rectally (cats 2-4 mg/cat) and can be repeated q 6-8 hr prn. Acepromazine or chlorpromazine may also be effective since they are 5-HT2 receptor antagonists and propranolol is a 5-HT1A receptor antagonist. Nitroglycerin may help to alleviate serotonin syndrome through nitric oxide mediated downregulation of serotonin.

There is no diagnostic test for serotonin syndrome because the increase in serotonin is at synapse, not in serum. There is a large list of differential diagnoses including other toxins like metaldehyde, lead and antifreeze and encephalitic syndromes like rabies and canine distemper. Signs generally resolve over 12-24 hours with symptomatic treatment. The prognosis worsens if DIC or rhabdomyolysis develops.

Alprazolam

Alprazolam (Xanax) is a benzodiazepine. The mechanism of action is uncertain but it may antagonize serotonin or act as GABA agonist. Alprazolam has a fairly wide margin of safety unless mixed with other CNS depressants. The duration of action is short. CNS and respiratory depression are most common following exposure. Many patients will be ataxic, drooling and depressed. Some patients will instead be disoriented, agitated, vocalizing. Some patient may show paradoxical dysphoria (very young, very old, or very high doses).

Treatment includes emesis if the patient is asymptomatic and/or activated charcoal if it is safe to give. Flumazenil is used as a reversal agent for severe CNS depression. For agitation, a low dose of acepromazine can be used. Provide symptomatic and supportive care including thermoregulation and confine and keep away from obstacles for 24 hrs.

Baclofen

Baclofen is a centrally acting skeletal muscle relaxant which has a narrow margin of safety in dogs. Signs observed at doses < 1mg/kg and death has been observed at 4.4mg/kg and above. Common signs include hypersalivation, depression, vocalization, ataxia, respiratory depression and tremors. Other possible signs include bradycardia, seizure activity, recumbency and coma. The onset of clinical signs can be as early as 15 minutes post exposure, and as late as 7 hours post exposure. Clinical signs may last for several days in large overdoses.

Treatment includes emesis if the patient is asymptomatic and/or activated charcoal if it is safe to give. Symptomatic and supportive care includes IV fluid therapy at twice maintenance using a balanced electrolyte solution since fluid diuresis may enhance elimination. Pull a baseline chemistry panel with electrolytes and repeat as needed. Vocalization has been successfully managed with cyproheptadine.

Provided adequate ventilatory support is available, the prognosis is generally good but seizing animals have a guarded prognosis. No long term sequela are expected.

Related Content:

Medical
Traditional and holistic treatments for giardia
Traditional and holistic treatments for giardia
3 Must-reads for National Poison Prevention Week
3 Must-reads for National Poison Prevention Week
UC Davis study on eye diseases in kittens
UC Davis study on eye diseases in kittens

Advertisement

Latest News

Pet Advocacy Network honors outstanding contributions to the pet care community

Traditional and holistic treatments for giardia

ASU trustees approve the creation of a new veterinary school

6 tips for first-time dog owners

View More Latest News
Advertisement